Clinical Trials List
2024-01-01 - 2027-12-31
Phase III
Recruiting4
ICD-10L11.8
Other specified acantholytic disorders
ICD-10L11.9
Acantholytic disorder, unspecified
ICD-10L57.2
Cutis rhomboidalis nuchae
ICD-10L57.4
Cutis laxa senilis
ICD-10L66.4
Folliculitis ulerythematosa reticulata
ICD-10L85.8
Other specified epidermal thickening
ICD-10L87.1
Reactive perforating collagenosis
ICD-10L87.2
Elastosis perforans serpiginosa
ICD-10L87.8
Other transepidermal elimination disorders
ICD-10L90.3
Atrophoderma of Pasini and Pierini
ICD-10L90.4
Acrodermatitis chronica atrophicans
ICD-10L90.8
Other atrophic disorders of skin
ICD-10L91.8
Other hypertrophic disorders of the skin
ICD-10L92.2
Granuloma faciale [eosinophilic granuloma of skin]
ICD-10L94.3
Sclerodactyly
ICD-10L94.8
Other specified localized connective tissue disorders
ICD-10L98.5
Mucinosis of the skin
ICD-10L98.6
Other infiltrative disorders of the skin and subcutaneous tissue
ICD-10L99
Other disorders of skin and subcutaneous tissue in diseases classified elsewhere
ICD-9701.8
Other specified hypertrophic and atrophic conditions of skin
-
Sponsor
-
Trial scale
Taiwan Multiple Center
-
Update
2026/02/01
Investigators and Locations
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Yu-Huei Huang Division of Dermatology
- Chun-Bing Chen Division of Dermatology
- Chung-Yao Hsu Division of Dermatology
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
220 participants
-
Global
220 participants
